Telemedicine-enabled clinical trial of metformin in patients (pts) with biochemically-recurrent prostate cancer (PCa).

Matt D. Galsky(University of California, San Francisco), William Oh(Eunice Kennedy Shriver National Institute of Child Health and Human Development), Reza Mehrazin(Icahn School of Medicine at Mount Sinai), Charles Baker(Icahn School of Medicine at Mount Sinai), Ashley Olson(MRC Human Nutrition Research), Amanda Leiter(Icahn School of Medicine at Mount Sinai), Mohamed Shahin(Icahn School of Medicine at Mount Sinai), David R. Shaffer(Memorial Sloan Kettering Cancer Center), Kiev Gimpel-Tetra(Icahn School of Medicine at Mount Sinai), John J. Holland(Los Angeles Clinical Trials), Tomasz Sablinski(Icahn School of Medicine at Mount Sinai), Patricia Acon(Icahn School of Medicine at Mount Sinai), Che‐Kai Tsao(Mount Sinai Hospital), John P. Sfakianos(Mount Sinai Medical Center)
Journal of Clinical Oncology
February 20, 2017
Cited by 2


Related Papers